A Phase 2 Study to Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early, Untreated Parkinson's Disease
Clinical trial NCT07322887 · RECRUITING
Trial details
- NCT number
- NCT07322887
- Sponsor
- GEN İlaç ve Sağlık Ürünleri A.Ş.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-21
- Primary completion
- 2027-05-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.